001     277102
005     20240229155009.0
024 7 _ |a 10.1158/1055-9965.EPI-23-0453
|2 doi
024 7 _ |a pmid:37351909
|2 pmid
024 7 _ |a 1055-9965
|2 ISSN
024 7 _ |a 1538-7755
|2 ISSN
024 7 _ |a altmetric:150598926
|2 altmetric
037 _ _ |a DKFZ-2023-01267
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a King, Sontoria D
|0 0009-0006-0549-5868
|b 0
245 _ _ |a Genetic susceptibility to nonalcoholic fatty liver disease and risk for pancreatic cancer: Mendelian randomization.
260 _ _ |a Philadelphia, Pa.
|c 2023
|b AACR
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1694094996_25273
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2023 Sep 1;32(9):1265-1269
520 _ _ |a There are conflicting data on whether nonalcoholic fatty liver disease (NAFLD) is associated with susceptibility to pancreatic cancer (PC). Using Mendelian randomization (MR), we investigated the relationship between genetic predisposition to NAFLD and risk for PC.Data from genome-wide association studies within the Pancreatic Cancer Cohort Consortium (PanScan; cases n=5090, controls n=8733) and the Pancreatic Cancer Case Control Consortium (PanC4; cases n=4,163, controls n=3,792) were analyzed. We used data on 68 genetic variants with four different MR methods (inverse variance weighting [IVW], MR-Egger, simple median, and penalized weighted median) separately to predict genetic heritability of NAFLD. We then assessed the relationship between each of the four MR methods and PC risk, using logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (CIs), adjusting for PC risk factors, including obesity and diabetes.No association was found between genetically predicted NAFLD and PC risk in the PanScan or PanC4 samples (e.g., PanScan, IVW OR=1.04, 95% CI: 0.88-1.22, MR-Egger OR=0.89, 95% CI: 0.65-1.21; PanC4, IVW OR=1.07, 95% CI: 0.90-1.27, MR-Egger OR=0.93, 95% CI: 0.67-1.28). None of the four MR methods indicated an association between genetically predicted NAFLD and PC risk in either sample.Genetic predisposition to NAFLD is not associated with PC risk.Given the close relationship between NAFLD and metabolic conditions, it is plausible that any association between NAFLD and PC might reflect host metabolic perturbations (e.g., obesity, diabetes, or metabolic syndrome) and does not necessarily reflect a causal relationship between NAFLD and PC.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Veliginti, Swathi
|0 0009-0004-3578-6581
|b 1
700 1 _ |a Brouwers, Martijn C G J
|0 0000-0002-8229-3331
|b 2
700 1 _ |a Ren, Zhewen
|0 0009-0008-0065-4529
|b 3
700 1 _ |a Zheng, Wei
|0 0000-0003-1226-070X
|b 4
700 1 _ |a Setiawan, Veronica Wendy
|0 0000-0001-9239-5692
|b 5
700 1 _ |a Wilkens, Lynne R
|0 0000-0001-8408-4536
|b 6
700 1 _ |a Shu, Xiao-Ou
|0 0000-0002-0711-8314
|b 7
700 1 _ |a Arslan, Alan A
|0 0000-0002-7775-8085
|b 8
700 1 _ |a Beane Freeman, Laura E
|0 0000-0003-1294-4124
|b 9
700 1 _ |a Bracci, Paige M
|0 0000-0001-9338-9307
|b 10
700 1 _ |a Canzian, Federico
|0 P:(DE-He78)5323704270b6393dcea70186ffd86bca
|b 11
|u dkfz
700 1 _ |a Du, Mengmeng
|0 0000-0001-6156-1491
|b 12
700 1 _ |a Gallinger, Steven J
|0 0000-0002-6998-9414
|b 13
700 1 _ |a Giles, Graham G
|0 0000-0003-4946-9099
|b 14
700 1 _ |a Goodman, Phyllis J
|0 0000-0001-9660-7074
|b 15
700 1 _ |a Haiman, Christopher A
|0 0000-0002-0097-9971
|b 16
700 1 _ |a Kogevinas, Manolis
|0 0000-0002-9605-0461
|b 17
700 1 _ |a Kooperberg, Charles
|0 0000-0002-7986-8560
|b 18
700 1 _ |a Le Marchand, Loic
|0 0000-0001-5013-980X
|b 19
700 1 _ |a Neale, Rachel E
|0 0000-0001-7162-0854
|b 20
700 1 _ |a Visvanathan, Kala
|0 0000-0002-0582-8005
|b 21
700 1 _ |a White, Emily
|0 0000-0003-0544-1633
|b 22
700 1 _ |a Albanes, Demetrius
|0 0000-0001-8330-4293
|b 23
700 1 _ |a Andreotti, Gabriella
|0 0000-0002-1096-3324
|b 24
700 1 _ |a Babic, Ana
|0 0000-0003-1199-5958
|b 25
700 1 _ |a Berndt, Sonja I
|0 0000-0001-5230-0652
|b 26
700 1 _ |a Brais, Lauren K
|0 0000-0003-1069-0407
|b 27
700 1 _ |a Brennan, Paul
|0 0000-0002-0518-8714
|b 28
700 1 _ |a Buring, Julie E
|0 0000-0003-2648-8692
|b 29
700 1 _ |a Rabe, Kari G
|0 0000-0002-7313-1875
|b 30
700 1 _ |a Bamlet, William R
|0 0000-0003-2903-1284
|b 31
700 1 _ |a Chanock, Stephen J
|0 0000-0002-2324-3393
|b 32
700 1 _ |a Fuchs, Charles S
|0 0000-0003-1582-9842
|b 33
700 1 _ |a Gaziano, J Michael
|0 0000-0002-5384-9767
|b 34
700 1 _ |a Giovannucci, Edward L
|0 0000-0002-6123-0219
|b 35
700 1 _ |a Hackert, Thilo
|0 0000-0002-7012-1196
|b 36
700 1 _ |a Hassan, Manal M
|0 0000-0002-8413-449X
|b 37
700 1 _ |a Katzke, Verena
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 38
|u dkfz
700 1 _ |a Kurtz, Robert C
|0 0009-0002-6493-3136
|b 39
700 1 _ |a Lee, I-Min
|b 40
700 1 _ |a Malats, Nuria
|0 0000-0003-2538-3784
|b 41
700 1 _ |a Murphy, Neil
|0 0000-0003-3347-8249
|b 42
700 1 _ |a Oberg, Ann L
|0 0000-0003-2539-9807
|b 43
700 1 _ |a Orlow, Irene
|0 0000-0001-6234-6961
|b 44
700 1 _ |a Porta, Miquel
|0 0000-0003-1684-7428
|b 45
700 1 _ |a Real, Francisco X
|0 0000-0001-9501-498X
|b 46
700 1 _ |a Rothman, Nathaniel
|0 0000-0001-6924-0895
|b 47
700 1 _ |a Sesso, Howard D
|0 0000-0002-9698-9954
|b 48
700 1 _ |a Silverman, Debra T
|0 0000-0001-8894-0301
|b 49
700 1 _ |a Thompson, Ian M
|0 0000-0003-0833-952X
|b 50
700 1 _ |a Wactawski-Wende, Jean
|0 0000-0003-3096-9595
|b 51
700 1 _ |a Wang, Xiaoliang
|0 0000-0001-5184-2935
|b 52
700 1 _ |a Wentzensen, Nicolas
|0 0000-0003-1251-0836
|b 53
700 1 _ |a Yu, Herbert
|0 0000-0003-3950-4815
|b 54
700 1 _ |a Zeleniuch-Jacquotte, Anne
|0 0000-0001-9350-1303
|b 55
700 1 _ |a Yu, Kai
|0 0000-0002-5337-137X
|b 56
700 1 _ |a Wolpin, Brian M
|0 0000-0002-0455-1032
|b 57
700 1 _ |a Duell, Eric J
|0 0000-0001-5256-0163
|b 58
700 1 _ |a Li, Donghui
|0 0000-0002-7542-0662
|b 59
700 1 _ |a Hung, Rayjean J
|0 0000-0002-4486-7496
|b 60
700 1 _ |a Perdomo, Sandra
|0 0000-0001-7740-8141
|b 61
700 1 _ |a McCullough, Marjorie L
|0 0000-0003-3025-6341
|b 62
700 1 _ |a Freedman, Neal D
|0 0000-0003-0074-1098
|b 63
700 1 _ |a Patel, Alpa V
|0 0000-0001-9997-1218
|b 64
700 1 _ |a Peters, Ulrike
|0 0000-0001-5666-9318
|b 65
700 1 _ |a Riboli, Elio
|0 0000-0001-6795-6080
|b 66
700 1 _ |a Sund, Malin
|0 0000-0002-7516-9543
|b 67
700 1 _ |a Tjønneland, Anne
|0 0000-0003-4385-2097
|b 68
700 1 _ |a Zhong, Jun
|0 0000-0002-3700-9434
|b 69
700 1 _ |a Van Den Eeden, Stephen K
|0 0000-0002-5599-8387
|b 70
700 1 _ |a Kraft, Peter
|0 0000-0002-4472-8103
|b 71
700 1 _ |a Risch, Harvey A
|0 0000-0001-5337-3941
|b 72
700 1 _ |a Amundadottir, Laufey T
|0 0000-0003-1859-8971
|b 73
700 1 _ |a Klein, Alison P
|0 0000-0003-2737-8399
|b 74
700 1 _ |a Stolzenberg-Solomon, Rachael Z
|0 0000-0003-3698-7006
|b 75
700 1 _ |a Antwi, Samuel O
|0 0000-0003-2372-9489
|b 76
773 _ _ |a 10.1158/1055-9965.EPI-23-0453
|g p. EPI-23-0453
|0 PERI:(DE-600)2036781-8
|n 9
|p 1265-1269
|t Cancer epidemiology, biomarkers & prevention
|v 32
|y 2023
|x 1055-9965
909 C O |p VDB
|o oai:inrepo02.dkfz.de:277102
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)5323704270b6393dcea70186ffd86bca
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 38
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2023
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-10
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-08-19
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER EPIDEM BIOMAR : 2022
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-19
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-08-19
920 1 _ |0 I:(DE-He78)C055-20160331
|k C055
|l C055 Genomische Epidemiologie
|x 0
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C055-20160331
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21